“…SNP‐array technology enables the detection of copy number variations (CNVs) and regions of homozygosity (ROH) in the genome. ROH are not per se diagnostic of specific diseases, but represent an important tool for revealing uniparental disomy (UPD), consanguinity or ancestral relatedness (Kearney, Kearney, & Conlin, 2011; Travaglini et al, 2017) and mapping recessive disease genes (Alkuraya, 2010; McQuillan et al, 2008). Massive parallel sequencing has improved the identification of single nucleotide changes, with a significant impact on the diagnostic yield for patients affected by neurodevelopmental disabilities and/or congenital anomalies (Alesi et al, 2018; Bamshad, Nickerson, & Chong, 2019; Petrikin, Willig, Smith, & Kingsmore, 2015).…”